NDC 51662-1213
25% Dextrose Infant
25% Dextrose Infant
25% Dextrose Infant is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Health First. The primary component is Dextrose Monohydrate.
| Product ID | 51662-1213_8062b1d2-a919-2504-e053-2991aa0af636 |
| NDC | 51662-1213 |
| Product Type | Human Prescription Drug |
| Proprietary Name | 25% Dextrose Infant |
| Generic Name | 25% Dextrose Infant |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-08-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019445 |
| Labeler Name | HF Acquisition Co. LLC, DBA Health First |
| Substance Name | DEXTROSE MONOHYDRATE |
| Active Ingredient Strength | 250 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |